A trial to assess first-line therapy with trastuzumab in patients with HER2 positive, metastatic breast cancer who were pre-exposed to trastuzumab for non-metastatic disease treatment

Trial Profile

A trial to assess first-line therapy with trastuzumab in patients with HER2 positive, metastatic breast cancer who were pre-exposed to trastuzumab for non-metastatic disease treatment

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Oct 2014

At a glance

  • Drugs Trastuzumab (Primary)
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top